Latest news
INmune Bio Advances Ebstrocel Regulatory Filings and Clinical Plans - sekbernews.idsekbernews.id · Sat, 08 Aug 2026 08:00:22 GMTINmune Bio Inc. - Common stock (INMB) Stock Price, News, Quote & History - FinancialContentFinancialContent · Fri, 07 Aug 2026 09:10:00 GMTINmune Bio Inc (INMB) (Q2 2026) Earnings Call Highlights: Regulatory Wins and Strategic Focus ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:08:00 GMTINmune Bio Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 03:03:00 GMTINmune Bio Q2 2026 earnings: Tax rebate benefit narrows net loss - TradingKeyTradingKey · Thu, 06 Aug 2026 21:49:15 GMTINMB: Ebstrocel nears global filings as financials strengthen and XPro advances in Alzheimer's - TradingViewTradingView · Thu, 06 Aug 2026 21:30:58 GMTINmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:00:00 GMTINMB: Regulatory progress and clinical advances drove a sharply reduced net loss and strengthened outlook - TradingViewTradingView · Thu, 06 Aug 2026 00:40:00 GMT